Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin
- 1 April 2021
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (4) , 738-742
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Body surface area‐based vs concentration‐based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trialJournal of Surgical Oncology, 2019
- Accuracy and clinical utility of in vitro cytometric profiling to personalize chemotherapy: Preliminary findings of a systematic review and meta-analysis.Journal of Clinical Oncology, 2013
- Ex vivo programmed cell death and the prediction of response to chemotherapyCurrent Treatment Options in Oncology, 2006
- Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal originBritish Journal of Surgery, 2004
- TCL‐1, MTCP‐1 and TML‐1 gene expression profile in non‐leukemic clonal proliferations associated with ataxia‐telangiectasiaInternational Journal of Cancer, 2002
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Gemcitabine Plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Breast Cancer PatientsJournal of Clinical Oncology, 2000
- Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.Journal of Clinical Oncology, 1998
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerEuropean Journal of Cancer, 1997
- Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal ChemotherapyAnnals of Surgery, 1995